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ABSTRACT 
Objective: To investigate the relative importance of genetic and environmental 
influences on perinatal depression, and the genetic overlap between perinatal depression 
and non-perinatal depression. 
 
Method: Analyses were conducted using structural equation modeling for (1) a validated 
self-rated screening tool for perinatal depression, the lifetime version of the Edinburgh 
Postnatal Depression Scale, in 3,427 Swedish female twins, and (2) clinical diagnoses of 
depression separated into perinatal depression and non-perinatal depression in a Swedish 
population-based cohort of 580,006 sisters. 
 
Results: In the twin study, the heritability of perinatal depression was estimated at 54% 
(95% CI, 35-70%) with the remaining variance attributable to non-shared environment 
(46%; 95% CI, 31-65%). In the sibling design, the heritability of perinatal depression was 
estimated at 44% (95% CI, 35-52%), and the heritability of non-perinatal depression at 
32% (95% CI, 24-41%). Bivariate analysis showed that 14% of the total variance (or 
33% of the genetic variance) in perinatal depression was unique for perinatal depression. 
 
Conclusions: The heritability estimate is higher for perinatal depression than for non-
perinatal depression. Further, a third of the genetic contribution is unique to perinatal 
depression and not shared with non-perinatal depression, suggesting only partially 
overlapping genetic etiologies for perinatal depression and non-perinatal depression. We 
suggest that perinatal depression constitutes a more homogenous subset of depression 
that could be prioritized for genomic discovery efforts. Further, these findings have direct 
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translational impact that can assist clinicians in the counsel of their patients regarding risk 
and prognosis of perinatal depression. 
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INTRODUCTION 
Perinatal depression, defined as depressive illness occurring during pregnancy (antenatal 
depression) or following childbirth (postpartum depression), impacts at least 10-15% of 
women, and confers substantial morbidity, mortality, and personal and societal costs.(1-
4) The clinical presentation of perinatal depression features low mood, anxiety, 
rumination, and in severe cases suicidal or infanticidal ideation.(5) Historically, perinatal 
depression has been conspicuously under-studied as compared to major depressive 
disorder.(6) 
Major depressive disorder is defined as marked and persistent depressed mood associated 
with physical and cognitive signs and symptoms.(7) Depression is common, costly, and is 
projected to be the second leading cause of disability worldwide by 2020.(8-11) The 
heritability of major depressive disorder has been estimated at 31–42%.(12,13) In 
contrast to other major psychiatric disorders, discerning the genetic basis of depression 
has proven to be more challenging. Genome-wide linkage studies, candidate gene studies, 
and genome-wide association studies have not been successful in identifying risk loci that 
meet contemporary standards for replication.(14) The relatively modest heritability of 
depression, as compared to other major psychiatric disorders, may be one reason for the 
substantially lower yield of identified genetic loci.(15) Another reason is that depression 
is a markedly heterogeneous disorder. 
In contrast, perinatal depression may represent a more homogenous disorder. Perinatal 
depression occurs in women of reproductive age and is coupled to pregnancy and 
childbirth. The limited literature on the genetic basis of perinatal depression suggests a 
heritable component that may be greater than in major depressive disorder.(16-18) There 
are two small studies showing clustering in families.(17,18) Murphy-Eberenz et al. 
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reported odds ratios for prediction of sibling status for perinatal depression or postpartum 
depression between 2.28-3.96.(17) Forty et al. studied female siblings and described 
familiality for postpartum depression maximized with a postpartum onset definition of 6–
8 weeks following childbirth (tetrachoric correlation coefficient=0.62, 95% CI=0.16-
0.88; p=0.01) in women with recurrent depression.(18) Finally, an Australian study of 
1,676 twins estimated heritability of lifetime postpartum depression at 25%.(16) 
Some have argued that perinatal depression is partly or wholly distinct from major 
depressive disorder. According to this view, the biological underpinnings of perinatal 
depression differ from those in non-perinatal depression in that sensitivity to the dramatic 
fluctuations in gonadal hormone serum concentrations during the perinatal period 
probably play a pathogenic role.(19,20) This implies that perinatal depression and non-
perinatal depression are at least partially different disorders where perinatal depression 
features distinctive genetic and environmental etiological risk factors. The alternative 
viewpoint is that perinatal depression is merely an episode of major depressive disorder 
occurring in the temporal period beginning during pregnancy or the immediate 
postpartum. Given the uncertainty about the degree to which perinatal depression and 
non-perinatal depression are distinct and the limited literature on the genetic basis of 
depression during the perinatal period, there is a great need for improved understanding 
of the genetic basis of perinatal depression, and the extent to which perinatal depression 
and non-perinatal depression overlap genetically. In this study, we used data from a 
validated screening tool for perinatal depression in 3,427 twins from the Swedish Twin 
Registry to estimate the relative contributions of genetic (heritability) and environmental 
risk factors to the liability to perinatal depression in a classical twin design. We then used 
Swedish population data from over 580,000 sisters and national treatment registers to 
estimate the heritability of perinatal depression, the heritability of non-perinatal 
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depression, and the genetic and environmental overlap between the two. 
METHODS 
Classical twin study 
Study population. The Swedish Twin Registry contains almost 200,000 Swedish twins 
born between 1886-2008.(21) The sub-study “Screening Across the Lifespan Twin study: 
the Younger” (SALTY) was conducted between 2009-2010 and included 11,372 twins 
from the Swedish Twin Registry with a median birth year of 1950 (54.3% female). The 
SALTY study included an extensive self-report questionnaire that covered many different 
areas, including perinatal depression.(22) The sample consisted of females from the 
SALTY study who reported having given birth to a living child, and who completed the 
lifetime Edinburgh Postnatal Depression Scale. This included 3,427 individual twins 
(1,516 female monozygotic and 1,911 female same-sex dizygotic twins) and both 
members of 1,106 twin pairs. Zygosity was determined using DNA for 27% of the twin 
females. For the remainder, zygosity was assigned based on questions about intra-pair 
physical similarities in childhood.(21) 
Perinatal depression classification. We assessed onset of mood symptoms both during 
pregnancy and postpartum using a retrospective lifetime version of the Edinburgh 
Postnatal Depression Scale, previously described in detail.(23) The Edinburgh Postnatal 
Depression Scale is the most widely used patient-rated assessment instrument for 
perinatal depressive illness in the world and has demonstrated good sensitivity and 
specificity in both antenatal and postpartum depression.(2,24) The lifetime version of the 
Edinburgh Postnatal Depression Scale includes the same 10 items used in the original 
scale, but was modified to assess previously experienced (or lifetime) perinatal 
depression.(23) A score of ≥12 on the scale is the accepted standard cut-off to identify 
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depressive illness and has been widely used in the literature, and was used in this study to 
define a binary outcome.(24,25) 
Statistical analysis. The classical twin methodology relies on the different relatedness 
between monozygotic and dizygotic twins. Monozygotic twins are considered genetically 
identical whereas dizygotic twins share an average of 50% of their segregating alleles. If 
genes influence a trait, there will be more pronounced twin similarity within monozygotic 
than within dizygotic pairs. By modeling twin covariance structures in monozygotic and 
dizygotic pairs, the variation in a phenotype is decomposed into additive genetic (A), 
shared environmental (C), and non-shared environmental (E) factors.(26) We used a 
liability-threshold approach, assuming that the observed binary variable came from an 
underlying continuous liability of the trait.(26) A threshold was assumed, where a 1 was 
assigned if an individual had a liability greater than the threshold, and 0 otherwise. The 
distribution of underlying liabilities were assumed normal, and the correlations between 
these underlying normal distributions could be estimated.(27) The resulting tetrachoric 
correlations form the basis of the heritability analysis. Note that the key assumptions of 
normally distributed liability and equal-environments have strong empirical support.(28)  
Sibling design 
Study population. To evaluate genetic and environmental influences on perinatal 
depression and non-perinatal depression in a larger and more generalizable setting, we 
included a population-based cohort from Swedish national register data. We used the 
Swedish personal identification numbers to link national Swedish longitudinal registries 
with high accuracy. The Swedish Medical Birth Register covers 99% of all births since 
1973,(29) and was linked to the Multi-Generation Register that contains information of 
first-degree relatives for persons born 1932 and later.(30) The Medical Birth Register and 
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Multi-Generation Register were linked to the Swedish Twin Registry to obtain 
information on twins and their zygosity. All parous women who had given birth to their 
first child after 1973 were included. Further, the women had to be born in Sweden, could 
not have emigrated and moved back to Sweden more than once, and had to have at least 
one sister fulfilling the same criteria. Due to the low observed occurrence of perinatal 
depression in the registers (0.6%; Table 2), we opted for a design that included up to four 
full or half-siblings per nuclear family, covering 99.8% of the eligible population. We 
identified a total of 580,006 parous female siblings from 260,384 unique families. This 
allowed for comparisons in 313,632 full-sister pairs, 28,568 maternal half-sister pairs, 
33,931 paternal half-sister pairs, 2,104 dizygotic twin sister pairs, and 2,225 monozygotic 
twin sister pairs. A total of 1,572 twin sisters overlapped between the two different 
designs. 
Disease classification. We linked all subjects in the study population to the Swedish 
National Patient Register, containing all Swedish psychiatric inpatient admissions since 
1973, and psychiatric specialist outpatient treatment contacts since 2001.(31) The register 
contains admission dates along with the main discharge diagnosis code, and up to eight 
secondary diagnosis codes in accordance with the International Classification of Disease 
(ICD). Treatment contacts for depression were defined using diagnostic codes: ICD-8 
296.00, 296.40, 296.41, 790.20; ICD-9 296.2, 296.3, 296.9, 298.0, 300.4, 309.0, 309.1, 
and 311; or ICD-10 F32.0, F32.1, F32.2, F32.3, F32.8, F32.9, F33.0, F33.1, F33.2, F33.3, 
F33.4, F33.8, F33.9, F34.1, and F41.2. These diagnostic codes were selected to capture as 
many women with perinatal depressive symptoms as possible. The perinatal period was 
defined as any point from estimated date of conception through six-months postpartum. 
Although the onset of postpartum depression is often within 4-6 weeks of childbirth,(7) 
we have intentionally expanded our definition to include women seeking care up to six 
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months postpartum, as treatment onset may be substantially delayed from symptom 
onset. Many women delay seeking treatment due to concerns of stigma of mental health 
treatment,(32) uncertainty about the nature of symptoms (postpartum “blues” or a normal 
transition to motherhood versus an illness state requiring treatment), or perceived lack of 
time for self-care.(33) 
The conception date was calculated using the birthdate of the child and gestational age at 
delivery. Perinatal depression was defined as ≥1 inpatient or outpatient treatment contact 
for unipolar depression within a perinatal period. Non-perinatal depression was defined 
as unipolar depression at any other time in a woman’s life. 
The perinatal period was further separated into an antenatal and a postnatal period to 
allow heritability estimation of antenatal and postnatal depression respectively. For this 
purpose, the postnatal period was extended to 12 months. 
Statistical analysis. To estimate the relative importance of genetic and environmental 
effects, we considered up to four female siblings simultaneously in family clusters. The 
family clusters included siblings who shared at least one parent, allowing full and half-
siblings within a family. No individual was included in more than one cluster and no 
known sibling relations existed between clusters. If half siblings were clustered into more 
than one family, only the largest family was included to avoid duplicate entries. If a 
family cluster consisted of more than four individuals, four individuals were randomly 
selected. 
As in the classical twin design, monozygotic and dizygotic twins were assumed to share 
100% and 50% of their additive genetic factors, A; the corresponding values were 50% 
for full siblings, and 25% for maternal and paternal half siblings. The shared 
environment, C, was modeled to be fully shared by all sibling types except paternal half 
	
	
11
siblings were it was assumed unshared as Swedish half siblings are much more likely to 
live with their mother.(34) Individual specific environment (E) was modeled to be unique 
to each individual. Relying on these assumptions we could determine the expected 
correlation structures for each specific type of family cluster depending on the sibling 
types were included. We again used the liability-threshold approach for analysis of the 
binary traits. We fitted univariate models where the variance in each disease separately 
were modeled to be due to A, C, and E. We then fit bivariate models where the variance 
and covariance in each trait were simultaneously modeled to be due to A, C, and E. To 
estimate how much of the variance in perinatal depression that could be attributed to A, 
C, and E in common with non-perinatal depression and A, C, and E unique to perinatal 
depression we used a Cholesky decomposition approach.(26) As this was modeled in a 
regression framework, we adjusted the prevalences for whether the family included half-
siblings as well as for birth year (both linear and squared). Non-perinatal depression was 
additionally adjusted for time at risk (linear and squared) and perinatal depression for 
number of offspring. 
Statistical software 
Data were prepared using SAS v9.3. Analyses were performed using the OpenMx 
package in R 3.0.2. In the twin-only analysis, missing values were handled by full 
information maximum likelihood. No missing values existed for the diseases and 
covariates in the sibling analyses. 
Role of the Sponsor: The sponsors had no role in the design and conduct of the study; 
collection, management, analysis, and interpretation of the data; preparation, review, or 
approval of the manuscript; and decision to submit the manuscript for publication. 
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Ethical approval 
The study was approved by the regional ethics committee in Stockholm. 
RESULTS 
Classical twin design 
The observed occurrence of perinatal depression in the twin sample (lifetime Edinburgh 
Postnatal Depression Scale total score ≥12) was 7.6% (Table 1). In the ACE model, there 
was no significant common environmental effect, and therefore we fitted a model where 
C-parameter was fixed at zero (AE model) that did not fit the data significantly worse 
(χ2=0.00, degrees of freedom=1, p-value=1.00). The heritability of perinatal depression 
based on the lifetime Edinburgh Postnatal Depression Scale was estimated at 54% (95% 
CI, 35-70%) with the remaining variance due to non-shared environment (46%) (Table 
1). 
Sibling design 
Based on treatment contacts, the observed occurrence of perinatal depression was 0.6% 
(Table 2). The heritability of perinatal depression was estimated at 44% (95% CI, 35-
52%), with the remaining variance attributable to non-shared environment (Table 2). The 
heritability of non-perinatal depression was estimated at 32% (95% CI, 24-41%), with the 
remaining variance attributable to shared environment (6%), and non-shared environment 
(62%) (Table 2). 
In a bivariate model all C-parameters, except C-unique for non-perinatal depression, was 
estimated close to zero. Therefore, we fitted an AE model where these parameters were 
set to zero, and the model fit did not deteriorate (χ2=0.53, degrees of freedom=2, p-
value=0.77). The bivariate analysis revealed that 14% of the total variance (or 33% of the 
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genetic variance) in perinatal depression was unique for perinatal depression and not in 
common with non-perinatal depression (Table 3 and Figure 1). 
The heritability of antenatal depression was estimated at 37% (95% CI, 27-47%), with 
the remaining variance attributable to non-shared environment, while the heritability of 
postnatal depression was estimated at 40% (95% CI, 31-49%) with the remaining 
variance attributable to non-shared environment (Table 4). 
DISCUSSION 
This is the largest and most comprehensive genetic epidemiological study of perinatal 
depression yet reported. Using Swedish national cohorts, we estimated the heritability of 
perinatal depression with two different approaches. Our classical twin design estimated 
the univariate heritability of perinatal depression at 54% (95% CI, 35-70%) and the 
sibling study estimated it at 44% (95% CI, 35-52%). Despite the marked difference in 
observed occurrence of perinatal depression in the two designs (0.6% and 7.6%), the 
heritability estimates are similar and the confidence intervals overlap, which suggests that 
both approaches capture the same underlying liability for perinatal depression. The 
different observed occurrence rates are likely explained by the different methodologies; 
self-report in the twin design, and register based treatment contacts in the sibling design. 
Thus, the sibling design did not account for women who did not seek treatment for 
perinatal depression but who would endorse symptoms on a self-report questionnaire.(35) 
To our knowledge, there has only been one previous heritability study of depression 
around pregnancy.(16) This Australian twin-study (N=1,676) estimated the heritability of 
lifetime postnatal depression at 25% (95% CI, 13-42%). Our estimates for lifetime 
perinatal depression at 54% (95% CI, 35-70%) in the twin design and at 44% (95% CI, 
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35-52%) in the sibling design, indicate a larger genetic contribution than in the Australian 
study. 
Division of the perinatal period allowed estimating the heritability of antenatal depression 
at 37% (95% CI, 27-47%) and postnatal depression at 40% (95% CI, 31-49%) (Table4). 
The variance of both antenatal and postnatal depression displayed a similar pattern as the 
variance of perinatal depression as a whole with variance explained by additive genetics 
of similar size and non-shared environment only, without contribution of shared 
environment. 
We estimated the heritability of non-perinatal depression at 32% (95% CI, 24-41%), 
which is slightly lower than previous estimates of major depressive disorder.(13) 
However, we only included parous women, and separated the perinatal and non-perinatal 
depressive episodes. 
In a bivariate heritability analysis of perinatal depression and non-perinatal depression, 
14% of the variance in perinatal depression was explained by genetic factors unique for 
perinatal depression and 28% by genetic factors shared with non-perinatal depression. In 
other words, of the total genetic variation for perinatal depression, 2/3 is shared with non-
perinatal depression and 1/3 is unique for perinatal depression.  
The heritability estimates of perinatal depression in these two analyses may have 
particularly important implication. A critical issue in genetic research in unipolar mood 
disorders is etiological heterogeneity. It is likely that there are multiple “types” of 
persistent depressive disorders. Considering these disorders as a single entity may 
effectively combine different sets of genetic and environmental etiological processes 
resulting in higher prevalence and lower heritability.(36-38) This combination is arguably 
unfavorable for genomic discovery efforts.(39) 
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Thus, we hypothesize that perinatal depression represents a form of unipolar mood 
disorder that could be prioritized for genomic discovery efforts. In effect, we suggest a 
“divide and conqueror” approach to understanding the genomics of unipolar mood 
disorders. Appropriately powered studies of perinatal depression could deliver genomic 
findings important to disentangling its etiology as well as of potential relevance to major 
depressive disorder. We note that women with perinatal depression are readily 
ascertained clinically enabling efficient accrual of large samples. Ultimately, improved 
identification of women at risk for perinatal depression could lead to targeted 
interventions to prevent, identify, and more effectively treat perinatal depression in order 
to minimize adverse sequelae for mother and child.  
The current study has several strengths. The study uses both classical twin and sibling 
designs. Two designs with different tools to measure perinatal depression; the validated 
Edinburgh Postnatal Depression Scale in 3,427 female twins, and treatment contacts from 
national Swedish registers in over 580,000 sisters that allowed for separation of 
depressive illness into perinatal depression and non-perinatal depression, and perinatal 
depression further into antenatal and postnatal depression. Additionally, sensitivity 
analyses suggested that the unique genetic component seen in perinatal depression was 
not explained by bipolar disorder or schizophrenia (see Supplement SA1), and that the 
unique genetic component was linked to the actual pregnancy (see Supplement SA2). 
This study also has limitations. The Swedish National Patient Register does not include 
outpatient admissions before 2001 and no primary care data. The percentage of women 
being treated for depression exclusively by the primary care in Sweden is not known, but 
the observed occurrence of perinatal depression based on treatment contacts is likely an 
underestimation of the true prevalence. Further, depression identified using the National 
Patient Register will likely be on the more severe end of the spectrum than depression 
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identified using the Edinburgh Postnatal Depression Scale. If the assumption of an 
underlying continuous liability in the threshold model is true this should not affect the 
heritability estimates. Indeed, increasing or decreasing the Edinburgh Postnatal 
Depression Scale cut-off to capture more or less severe depressive illness did not change 
the heritability estimates (see Supplement SA3). The observed outcome occurrence of 
perinatal depression among the twins using the Edinburgh Postnatal Depression Scale 
was 7.6%, which is lower than observed in other studies (10-15%).(1-4) This could be 
due to the participants being exclusively twins and the retrospective assessment, rather 
than being assessed at a maternal healthcare unit. When estimating the heritability of 
antenatal and postnatal depression respectively, the postnatal period had to be expanded 
to 12 months to include enough cases to allow estimation. While this deviates from the 
definition of perinatal depression that includes a six-month postnatal period, analysis of 
perinatal depression using a 12-month postnatal period revealed almost identical results 
with the heritability estimated at 43% (95% CI, 34-51%) and the remaining variance 
explained by non-shared environment (57%; 95% CI, 49-66%). We were not able to 
restrict the postnatal period to the first four or six weeks. However, an early onset 
depression might not lead to contact with the healthcare within this period and could 
therefor remain undetected when using treatment contact data. Examination of 
differences regarding timing of onset of symptoms in pregnancy versus postpartum has 
been a central issue in recent work,(40) and future research should focus on further 
elucidating the genetic and biological contributions to the timing of onset of symptoms. 
These findings provide important information that will assist clinicians as they counsel 
their patients regarding the risk and prognosis of perinatal mood disorders. For example, 
the heritability of a disorder has a direct translational impact in discussions between 
clinician and patients. Most patients will ask fundamental questions as to “why do I have 
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perinatal depression?”, “was it my fault?”, “what’s the risk next time?”. This study 
highlights the critical need for clinicians providing obstetrical care to obtain detailed 
information regarding the patient’s personal and family history of psychiatric illness that 
began in the perinatal period. Integration of genetic risk with environmental influences is 
vital for the appropriate tailoring of individual treatment and discussions of prognosis.  
In conclusion, we report the largest heritability studies of perinatal depression to date, 
indicating a larger heritability of perinatal depression than that for depression occurring 
outside of the perinatal period, and the first bivariate heritability study of perinatal and 
non-perinatal depression, revealing a third of the genetic variance unique for perinatal 
depression. We believe that perinatal depression represents a form of unipolar mood 
disorder that can be utilized by clinicians in discussions with their patients and could be 
prioritized for genomic discovery efforts. 
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FIGURES AND TABLES 
Table 1. Univariate heritability estimate of perinatal depression using classical twin 
design (N=3,427)* 
 
Table 2. Univariate heritability estimates of perinatal depression and non-perinatal 
depression using sibling design (N=580,006)* 
 
Table 3. Estimated variance in perinatal depression 
 
Table 4. Univariate heritability estimates of antenatal depression and postnatal 
depression using sibling design (N=580,006)* 
 
Figure 1. Estimated variance in perinatal depression* 
 
* Variance accounted for by genetic, shared environmental, and non-shared environmental 
effects for perinatal depression, either unique for perinatal depression or in common with non-
perinatal depression. No variance accounted for by shared environmental effects. 
	
Model Outcome Occurrence
Additive 
Genetic (A) Shared (C) 
Non-shared 
(E)
Monozygotic 
Twins
Dizygotic 
Twins
0.54 0.00 0.46 0.55 0.22
(0.00-0.70 (0.00-0.46) (0.30-0.66) (0.09) (0.14)
0.54 NA 0.46 0.55 0.22
(0.35-0.70) (0.31-0.65) (0.09) (0.14)
b An AE model, were the C parameter was fixed at zero, was considered as the estimate of C 
was zero in the ACE model.
a Profile likelihood confidence intervals.
Table 1. Univariate heritability estimate of perinatal depression using classical twin 
design (N=3,427)*
Abbreviations: CI, confidence interval. SE, standard error. NA, not applicable.
* Perinatal depression was defined using the lifetime Edinburgh Postnatal Depression Scale, 
where a score of ≥12 was used to define a binary outcome. The C component was not 
significant in the initial ACE model, and an AE model excluding the C component was fitted.
7.6%
Environment
Estimated Variance
(95% CI)a
Tetrachoric Correlation
(SE)
7.6%ACE
AEb
Model Outcome Occurrence
Additive 
Genetic (A) Shared (C) 
Non-shared 
(E)
0.44 0.00 0.56
(0.35-0.52) (0.00-0.01) (0.48-0.64)
SE
Positive 
concurrent 
pairsd
0.45 (0.15) 2
-0.83 (0.18) 0
0.23 (0.03) 56
0.01 (0.07) 4
0.05 (0.07) 5
0.44 NA 0.56
(0.35-0.52) (0.47-0.64)
SE
Positive 
concurrent 
pairsd
0.45 (0.15) 2
-0.83 (0.18) 0
0.23 (0.03) 56
0.01 (0.07) 4
0.05 (0.07) 5
0.32 0.06 0.62
(0.24-0.41) (0.02-0.10) (0.57-0.66)
SE
Positive 
concurrent 
pairsd
0.52 (0.06) 31
0.15 (0.10) 9
0.22 (0.01) 1,834
0.13 (0.02) 296
0.05 (0.02) 239Paternal Half-siblings
Abbreviations: NA, not applicable. CI, confidence interval. SE, standard error.
Full Siblings
Maternal Half-siblings
Table 2. Univariate heritability estimates of perinatal depression and non-perinatal 
depression using sibling design (N=580,006)*
Non-perinatal 
Depression
Perinatal 
Depression
Environment
Estimated Variance
(95% CI)a
ACE
ACE
AEc 0.6%
Tetrachoric Correlations
Disorder
Perinatal 
Depression
0.6%
Monozygotic Twins
Dizygotic Twins
Tetrachoric Correlations
Tetrachoric Correlations
5.4%
Monozygotic Twins
Dizygotic Twinsb
Full Siblings
Maternal Half-siblings
Paternal Half-siblings
Monozygotic Twins
Dizygotic Twinsb
Full Siblings
Maternal Half-siblings
Paternal Half-siblings
e Number of pairs consisting of two individuals positive for the disorder.
* Register based data on hospital admissions for depression was used to define perinatal 
depression and non-perinatal depression (see Methods). 
a Wald type confidence intervals, standard error calculated using the delta method.
c An AE model, were the C parameter was fixed at zero, was considered as the estimate 
of C was zero in the ACE model.
b No concordant dizygotic twin pairs for perinatal depression.
Model
Additive 
Genetic (A) -
uniqueb
Additive 
Genetic (A) - 
in commonc
Shared (C) 
uniqueb
Shared (C) - 
in commonc
Non-shared 
(E) - uniqueb
Non-shared 
(E) - in 
commonc 
0.16 0.26 0.00 0.00 0.42 0.17
(0.13-0.18) (0.20-0.32) (0.00-0.00) (0.00-0.01) (0.38-0.45) (0.14-0.20)
0.14 0.28 NA NA 0.42 0.16
(0.12-0.16) (0.22-0.35) (0.38-0.45) (0.13-0.19)
SE
Positive 
concurrent 
pairse
0.33 (0.10) 9
0.05 (0.29) 1
0.16 (0.01) 381
0.08 (0.03) 75
0.06 (0.02) 67
e Number of pairs consisting of one individual positive for perinatal depression, and the other positive 
for non-perinatal depression. Each pair contributes with two combinations; perinatal depression sibling 
1 vs. Non-perinatal depression sibling 2, and vice versa.
d An AE model, were the C parameter was fixed at zero, was considered as the estimate of C was zero 
in the ACE model (except C unique for non-perinatal depression).
a Wald type confidence intervals, standard error calculated using the delta method.
Environment
b Variance explained in perinatal depression by component unique for perinatal depression and not in 
common with non-perinatal depression.
c Variance explained in perinatal depression by component in common with non-perinatal depression.
Tetrachoric Correlations
Monozygotic Twins
Dizygotic Twins
Full Siblings
Maternal Half-siblings
Paternal Half-siblings
Table 3. Estimated variance in perinatal depression
ACE
AEd
Abbreviations: CI, confidence interval. NA, not applicable. SE, standard error.
Estimated variance
 (95% CI)a
Model Outcome Occurrence
Additive 
Genetic (A) Shared (C) 
Non-shared 
(E)
0.36 0.02 0.62
(0.27-0.45) (-0.04-0.09) (0.54-0.70)
0.37 NA 0.62
(0.27-0.47) (0.51-0.73)
SE concurrent 
-0.82 NAc 0
-0.64 NAc 0
0.24 (0.00) 18
0.15 (0.17) 2
0.04 (0.11) 2
0.40 0.00 0.60
(0.27-0.52) (-0.03-0.03) (0.49-0.71)
0.40 NA 0.60
(0.31-0.49) (0.51-0.69)
SE concurrent 
0.64 (0.13) 3
-0.84 NAc 0
0.19 (0.00) 33
0.08 (0.07) 6
0.07 (0.09) 3
AEb 0.3%
Postnatal 
Depression AE
b 0.4%
Dizygotic Twins
Tetrachoric Correlations
0.4%
c Problems with standard error estimates. No standard errors were obtained.
Full Siblings
Maternal Half-siblings
Monozygotic Twins
Table 4. Univariate heritability estimates of antental depression and postnatal 
depression using sibling design (N=580,006)*
Postnatal 
Depression
Antenatal 
Depression
Environment
Estimated Variance
(95% CI)a
ACE
ACE
Tetrachoric Correlations
Disorder
0.3%
Monozygotic Twins
Dizygotic Twins
Full Siblings
Maternal Half-siblings
Paternal Half-siblings
Antenatal 
Depression
d Number of pairs consisting of two individuals positive for the disorder.
Paternal Half-siblings
Abbreviations: NA, not applicable. CI, confidence interval. SE, standard error.
* Register based data on hospital admissions for depression was used to define antenatal 
depression (during pregnancy) and postnatal depression (within 12 months postpartum) 
(see Methods). 
a Wald type confidence intervals, standard error calculated using the delta method.
b An AE model, were the C parameter was fixed at zero, was considered as the estimate 
of C was zero in the ACE model.

